当前位置：首页 SCI 期刊医学 Genes And Diseases(非官网)

Genes And DiseasesSCIE

国际简称：Genes and Diseases 参考译名：基因与疾病

中科院分区
2区
CiteScore分区
Q1

基本信息：: ISSN：2352-3042; 是否OA：开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：Netherlands; 出版商：Elsevier; 出版语言：English; 研究方向：Biochemistry, Genetics and Molecular Biology-Biochemistry

评价信息：: CiteScore指数：7.3; SJR指数：1.446; SNIP指数：1.228

发文数据：: Gold OA文章占比：0.00%; 研究类文章占比：0.00%

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区发文数据常见问题

英文简介Genes And Diseases期刊介绍

Genes&Diseases, sponsored by Chongqing Medical University, is an all English open access (OA) journal that focuses on the combination of molecular medicine and translational medicine. Since its establishment in 2014, this journal has focused on the pathogenesis of human diseases and cutting-edge advances in precision medicine, timely publishing industry hotspots, and committed to publishing high-quality articles and reviews.

The magazine has a wide range of submissions, including but not limited to molecular biology, molecular genetics, cell biology, stem cell biology, developmental biology, gene regulation, epigenetics, cancer biology, immunity and infection, neuroscience, animal models, gene and cell therapy, and regenerative medicine. The journal aims to establish an advanced academic platform for international academic exchange and lead the forefront of disciplines.

期刊简介Genes And Diseases期刊介绍

《Genes And Diseases》是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 35 Weeks
国际TOP期刊
医学
BIOCHEMISTRY & MOLECULAR BIOLOGY
SCIE
中科院2区
非预警

Cite Score数据（2024年最新版）Genes And Diseases Cite Score数据

CiteScore：7.3
SJR：1.446
SNIP：1.228

学科类别	分区	排名	百分位
大类：Medicine 小类：Genetics (clinical)	Q1	22 / 99	78%
大类：Medicine 小类：Biochemistry	Q2	129 / 438	70%
大类：Medicine 小类：Molecular Biology	Q2	150 / 410	63%
大类：Medicine 小类：Cell Biology	Q2	118 / 285	58%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Genes And Diseases 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	2区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 GENETICS & HEREDITY 遗传学	2区 2区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

本刊中国学者近年发表论文

1、Cell cycle dysregulation with overexpression of KIF2C/MCAK is a critical event in nasopharyngeal carcinoma
Author: Zuo, Xiaofeng; Meng, Peixin; Bao, Yuxin; Tao, Chuntao; Wang, Yitao; Liu, Xianjun; Bu, Youquan; Zhu, Jiang

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 212-227. DOI: 10.1016/j.gendis.2021.05.003
2、Androgen receptor inhibits the hair follicle induction potential of dermal papilla cells by binding with Tcf4 at the A574 binding site
Author: Yu, Nanlan; Hu, Tianxing; Yang, Haichao; Zhang, Lian; Zhu, Lin; Zhou, Xiaofang; Xiang, Fei; Yang, Xichuan; Li, Yuhong

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 51-54. DOI: 10.1016/j.gendis.2022.04.015
3、Adipose-derived stem cells and obesity: The spear and shield relationship
Author: Yang, Hong; Li, Chaowei; Li, Yizhou; Tai, Ruiqing; Sun, Chao

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 175-186. DOI: 10.1016/j.gendis.2021.09.004
4、Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
Author: Yan, Yuanliang; Peng, Jinwu; Liang, Qiuju; Ren, Xinxin; Cai, Yuan; Peng, Bi; Chen, Xi; Wang, Xiang; Yi, Qiaoli; Xu, Zhijie

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 135-150. DOI: 10.1016/j.gendis.2021.10.004
5、Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies
Author: Xiao, Yuai; Xia, Yu; Wang, Yuchong; Xue, Chunyu

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 113-125. DOI: 10.1016/j.gendis.2021.08.0072352-3042
6、PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities
Author: Xiang, Jin; Wang, Kai; Tang, Ni

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 101-112. DOI: 10.1016/j.gendis.2022.02.010
7、Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials
Author: Song, Yanlin; Bi, Zhenfei; Liu, Yu; Qin, Furong; Wei, Yuquan; Wei, Xiawei

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 76-88. DOI: 10.1016/j.gendis.2022.05.006
8、Liquiritigenin promotes osteogenic differentiation and prevents bone loss via inducing auto-lysosomal degradation and inhibiting apoptosis
Author: Qiu, Yu; Zhao, Yueyang; Long, Zhimin; Song, Aijia; Huang, Peng; Wang, Kejian; Xu, Ling; Molloy, David Paul; He, Guiqiong

Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 284-300. DOI: 10.1016/j.gendis.2021.06.008